Sacubitril/Valsartan as a Therapeutic Tool Across the Range of Heart Failure Phenotypes and Ejection Fraction Spectrum.

Front Physiol · 2021 · PMC8419408 · PMID 34497530

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

trend toward significanceno p-value reported

Although with a promising trend toward significance, S/V did not reach the statistical power in the overall study population in the reduction of the composite primary outcome of cardiovascular death and total hospitalization for HF ( Solomon et al., 2019 ).

also in 304 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.